Organon & Co | OGN - Ebit





Ebit Cambio Fecha
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Celltrion KRW 13.41B 1.33B 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
Glaxosmithkline GBP 2.31B 14.92M 2026-03
Kangmei Pharma CNY -12.72M 13.97M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Merck USD 840M 2.72B 2026-06
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Novartis USD 4.18B 118M 2026-03
Organigram Holdings CAD -9.79M 10.33M 2026-03
Organon & Co USD 291M 33M 2026-06
Ovoca Bio EUR -173K 990K 2025-12
Pharma Mar EUR -1.4M 2.03M 2026-06
Qiagen NV USD 141.4M 44.52M 2026-06
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -389M 318.05M 2026-03